Tag Archives: drug

Rheumatology group urges CMS to use caution when considering IPI drug pricing model

In comments submitted to the Centers for Medicare and Medicaid Services, the American College of Rheumatology urged the agency to proceed with caution when considering the International Pricing Index drug pricing model, which was announced in an Advance Notice of Proposed Rulemaking in October. The ACR is concerned that, without substantial changes, the demonstration program… Read More »

Federal judge says HHS Secretary Alex Azar exceeded legal authority in setting 340B drug payment rates

A federal court has sided with the American Hospital Association and others in ruling that the Department of Health and Human Services unlawfully cut payment rates for certain outpatient drugs. HHS Secretary Alex Azar exceeded his legal authority in setting new reimbursement rates in the outpatient prospective payment system rule for 2018, United States District… Read More »

Former Aveo CFO found guilty of misleading investors about prospects for cancer drug

The SEC’s two-year battle with Aveo Pharmaceuticals over the company’s embattled kidney cancer drug tivozanib has come to a close with a jury verdict against its former chief financial officer, David Johnston. The guilty verdict—which followed two judgments against Aveo’s former chief executive officer and chief medical officer, plus a settlement that resulted in a… Read More »